Roselabs Finance

{
  "main_header": {
    "sid": 397394,
    "name": "Roselabs Finance",
    "stock_name": "Roselabs Finance",
    "full_name": "Roselabs Finance Ltd",
    "name_url": "stocks-analysis/roselabs-finance",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "23.90",
    "chg": 0.17,
    "chgp": "0.72%",
    "dir": 1,
    "prev_price": "23.73",
    "mcapval": "23.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531324,
    "symbol": "",
    "ind_name": "Non Banking Financial Company (NBFC)",
    "ind_code": 5,
    "indexname": "India SENSEX",
    "isin": "INE475C01012",
    "curr_date": "Apr 09",
    "curr_time": "",
    "bse_nse_vol": "1.53 k",
    "exc_status": "Active",
    "traded_date": "Apr 09, 2026",
    "traded_date_str": "2026 04 09",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/roselabs-finance-397394-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Are Roselabs Finance Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-roselabs-finance-ltd-latest-results-good-or-bad-3798961",
        "imagepath": "",
        "date": "2026-01-21 19:13:40",
        "description": "Roselabs Finance Ltd's latest financial results for Q3 FY26 present a complex picture. The company reported net sales of ₹1.21 crores, marking its first revenue generation in three quarters, following two consecutive quarters of zero sales. This indicates some level of operational activity, although the sustainability of this revenue remains uncertain given the prior performance.\n\nThe net loss for the quarter was ₹0.04 crores, which reflects a quarter-on-quarter improvement of 33.33% from the previous loss of ₹0.06 crores. Despite this improvement, the company continues to face significant challenges, as indicated by its negative operating profit margin of -2.48% and persistent losses over multiple quarters. The operating profit before depreciation, interest, and tax also showed a slight reduction in loss, reaching ₹-0.03 crores, which is the least negative figure in recent quarters.\n\nThe financial health o..."
      },
      {
        "title": "Roselabs Finance Q3 FY26: Mounting Losses Deepen Financial Distress",
        "link": "https://www.marketsmojo.com/news/result-analysis/roselabs-finance-q3-fy26-mounting-losses-deepen-financial-distress-3797027",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/RoselabsFinance_quaterlyResult_3797027.png",
        "date": "2026-01-20 19:15:59",
        "description": "Roselabs Finance Limited, the micro-cap non-banking financial company under the Lodha Group umbrella, reported a quarterly net loss of ₹0.04 crores for Q3 FY26 (October-December 2025), marking a marginal improvement from the ₹0.06 crore loss in Q2 FY26. With a market capitalisation of just ₹27.00 crores and a deeply negative book value of ₹-4.73 per share, the company remains entrenched in severe financial distress despite sporadic revenue generation."
      }
    ],
    "total": 206,
    "sid": "397394",
    "stock_news_url": "https://www.marketsmojo.com/news/roselabs-finance-397394"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "03-Apr-2026",
      "details": "Certificate under Regulation 74(5) of the SEBI (DP) Regulations 2018",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "23-Mar-2026",
      "details": "Intimation of closure of trading window",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "21-Jan-2026",
      "details": "Newspaper publication of the financial results for the quarter and nine months ended December 31 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Are Roselabs Finance Ltd latest results good or bad?

2026-01-21 19:13:40

Roselabs Finance Ltd's latest financial results for Q3 FY26 present a complex picture. The company reported net sales of ₹1.21 crores, marking its first revenue generation in three quarters, following two consecutive quarters of zero sales. This indicates some level of operational activity, although the sustainability of this revenue remains uncertain given the prior performance. The net loss for the quarter was ₹0.04 crores, which reflects a quarter-on-quarter improvement of 33.33% from the previous loss of ₹0.06 crores. Despite this improvement, the company continues to face significant challenges, as indicated by its negative operating profit margin of -2.48% and persistent losses over multiple quarters. The operating profit before depreciation, interest, and tax also showed a slight reduction in loss, reaching ₹-0.03 crores, which is the least negative figure in recent quarters. The financial health o...

Read full news article

Roselabs Finance Q3 FY26: Mounting Losses Deepen Financial Distress

2026-01-20 19:15:59

Roselabs Finance Limited, the micro-cap non-banking financial company under the Lodha Group umbrella, reported a quarterly net loss of ₹0.04 crores for Q3 FY26 (October-December 2025), marking a marginal improvement from the ₹0.06 crore loss in Q2 FY26. With a market capitalisation of just ₹27.00 crores and a deeply negative book value of ₹-4.73 per share, the company remains entrenched in severe financial distress despite sporadic revenue generation.

Read full news article

View All News